Follow
Bart Cornelissen
Bart Cornelissen
University Medical Centre Groningen / University of Oxford
Verified email at oncology.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
E Fokas, R Prevo, JR Pollard, PM Reaper, PA Charlton, B Cornelissen, ...
Cell death & disease 3 (12), e441-e441, 2012
4462012
Targeting the nucleus: an overview of Auger-electron radionuclide therapy
B Cornelissen, K A Vallis
Current drug discovery technologies 7 (4), 263-279, 2010
1362010
Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous …
K McLarty, B Cornelissen, DA Scollard, SJ Done, K Chun, RM Reilly
European journal of nuclear medicine and molecular imaging 36, 81-93, 2009
1352009
Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy
JC Knight, B Cornelissen
American journal of nuclear medicine and molecular imaging 4 (2), 96, 2014
992014
Selective permeabilization of the blood–brain barrier at sites of metastasis
JJ Connell, G Chatain, B Cornelissen, KA Vallis, A Hamilton, L Seymour, ...
Journal of the national cancer institute 105 (21), 1634-1643, 2013
982013
A review of small animal imaging planar and pinhole SPECT γ camera imaging
K Peremans, B Cornelissen, B Van Den Bossche, K Audenaert, ...
Veterinary Radiology & Ultrasound 46 (2), 162-170, 2005
932005
Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors
B Cornelissen, S Able, V Kersemans, PA Waghorn, S Myhra, K Jurkshat, ...
Biomaterials 34 (4), 1146-1154, 2013
922013
Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer …
K McLarty, B Cornelissen, Z Cai, DA Scollard, DL Costantini, SJ Done, ...
Journal of Nuclear Medicine 50 (8), 1340-1348, 2009
892009
PET imaging of PARP expression using 18F-olaparib
TC Wilson, MA Xavier, J Knight, S Verhoog, JB Torres, M Mosley, ...
Journal of Nuclear Medicine 60 (4), 504-510, 2019
852019
Imaging DNA damage in vivo using γH2AX-targeted immunoconjugates
B Cornelissen, V Kersemans, S Darbar, J Thompson, K Shah, K Sleeth, ...
Cancer research 71 (13), 4539-4549, 2011
842011
A comparison of the behavior of 64Cu-acetate and 64Cu-ATSM in vitro and in vivo
R Hueting, V Kersemans, B Cornelissen, M Tredwell, K Hussien, ...
Journal of Nuclear Medicine 55 (1), 128-134, 2014
812014
Cell penetrating peptides for in vivo molecular imaging applications
V Kersemans, K Kersemans, B Cornelissen
Current pharmaceutical design 14 (24), 2415-2427, 2008
812008
Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of 111In-DTPA-human epidermal growth factor in patients with metastatic EGFR …
KA Vallis, RM Reilly, D Scollard, P Merante, A Brade, S Velauthapillai, ...
American journal of nuclear medicine and molecular imaging 4 (2), 181, 2014
722014
18F-Trifluoromethanesulfinate Enables Direct C–H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides
CW Kee, O Tack, F Guibbal, TC Wilson, PG Isenegger, M Imiołek, ...
Journal of the American Chemical Society 142 (3), 1180-1185, 2020
692020
PARP inhibitors in cancer diagnosis and therapy
CY Chan, KV Tan, B Cornelissen
Clinical Cancer Research 27 (6), 1585-1594, 2021
682021
Targeting the tumour: Cell penetrating peptides for molecular imaging and radiotherapy
V Kersemans, B Cornelissen
Pharmaceuticals 3 (3), 600-620, 2010
612010
Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells
B Cornelissen, M Hu, K McLarty, D Costantini, RM Reilly
Nuclear medicine and biology 34 (1), 37-46, 2007
562007
Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality
V Kersemans, J Thompson, B Cornelissen, M Woodcock, PD Allen, ...
Journal of Nuclear Medicine 52 (11), 1827-1833, 2011
552011
The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of 111In-IGF-1 (E3R) in vivo and the clonogenic survival of breast cancer …
B Cornelissen, K McLarty, V Kersemans, RM Reilly
Nuclear medicine and biology 35 (6), 645-653, 2008
542008
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences
V Kersemans, B Cornelissen, MD Minden, J Brandwein, RM Reilly
Journal of Nuclear Medicine 49 (9), 1546-1554, 2008
532008
The system can't perform the operation now. Try again later.
Articles 1–20